Elizabeth B Humphreys

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.

Alan W Partin, A. Partin, P. Walsh, 2005, JAMA.

Radical prostatectomy for clinical stage T3a disease

Alan W Partin, A. Partin, P. Walsh, 2007, Cancer.

Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy.

Misop Han, Alan W Partin, Bruce J Trock, 2008, JAMA.

Predicting the outcome of prostate biopsy: comparison of a novel logistic regression‐based model, the prostate cancer risk calculator, and prostate‐specific antigen level alone

Georg Bartsch, Misop Han, Alan W Partin, 2009, BJU international.

Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005.

Alan W Partin, Danil V Makarov, Bruce J Trock, 2007, Urology.

Prediction of pathological stage based on clinical stage, serum prostate‐specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era

Misop Han, Alan W Partin, Bruce J Trock, 2017, BJU international.